Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Metal-response element-binding transcription factor 2 (MTF2)
- Target
- MTF2
- Molecular classification
- Transcription factor, Polycomb group protein, Chromatin-associated protein
01
Overview
Metal-response element-binding transcription factor 2 (MTF2) is a member of the polycomb group proteins and acts as a chromatin-associated transcription factor. It serves as a sub-stoichiometric component of the polycomb repressive complex 2 (PRC2), enhancing the recruitment of PRC2 to specific genomic sites such as Hox gene clusters and stabilizing trimethylation of lysine 27 on histone H3 (H3K27me3)[2][4]. MTF2 plays crucial roles in embryonic development, differentiation, and transcriptional silencing of target genes. While it is not a classical therapeutic target such as an enzyme or receptor, alterations in its function and expression are implicated in developmental disorders and cancer[2][5]. There are currently no drugs known to directly target MTF2.
- Other names
- PCL2Polycomb-like protein 2PCGF6-associated proteinMTF-2
02
Mechanism of action
Recruitment of polycomb repressive complex 2 (PRC2) to chromatin; Enhancement of H3K27 trimethylation (H3K27me3) via PRC2
03
Biological functions
Epigenetic regulationTranscriptional repressionRegulation of Hox gene expressionHistone modification (specifically trimethylation of H3K27 via PRC2 interaction)
04
Disease associations
CancerAbnormal development (by affecting Hox gene regulation)Other (potential impacts in stem cell differentiation)
05
Biomarkers
H3K27me3 levels at certain gene clusters, e.g., Hox cluster, may indirectly reflect MTF2/PRC2 activity[2][4]
Beyond the preview
Go deeper on Metal-response element-binding transcription factor 2 (MTF2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Metal-response element-binding transcription factor 2 (MTF2).